- Home
- SBCF vs NVAX Comparison
SBCF vs NVAX Comparison
Compare SBCF & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- NVAX
- Stock Information
- Founded
- SBCF 1926
- NVAX 1987
- Country
- SBCF United States
- NVAX United States
- Employees
- SBCF N/A
- NVAX N/A
- Industry
- SBCF Major Banks
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBCF Finance
- NVAX Health Care
- Exchange
- SBCF Nasdaq
- NVAX Nasdaq
- Market Cap
- SBCF 2.5B
- NVAX 1.4B
- IPO Year
- SBCF N/A
- NVAX 1995
- Fundamental
- Price
- SBCF $28.57
- NVAX $8.38
- Analyst Decision
- SBCF Buy
- NVAX Buy
- Analyst Count
- SBCF 4
- NVAX 6
- Target Price
- SBCF $29.00
- NVAX $17.83
- AVG Volume (30 Days)
- SBCF 376.1K
- NVAX 4.8M
- Earning Date
- SBCF 01-27-2025
- NVAX 02-26-2025
- Dividend Yield
- SBCF 2.59%
- NVAX N/A
- EPS Growth
- SBCF 15.45
- NVAX N/A
- EPS
- SBCF 1.42
- NVAX N/A
- Revenue
- SBCF $499,141,000.00
- NVAX $885,193,000.00
- Revenue This Year
- SBCF N/A
- NVAX N/A
- Revenue Next Year
- SBCF $7.91
- NVAX N/A
- P/E Ratio
- SBCF $19.57
- NVAX N/A
- Revenue Growth
- SBCF N/A
- NVAX N/A
- 52 Week Low
- SBCF $21.90
- NVAX $3.60
- 52 Week High
- SBCF $31.68
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- SBCF 59.84
- NVAX 45.04
- Support Level
- SBCF $27.43
- NVAX $8.30
- Resistance Level
- SBCF $28.71
- NVAX $9.77
- Average True Range (ATR)
- SBCF 0.75
- NVAX 0.56
- MACD
- SBCF 0.24
- NVAX -0.06
- Stochastic Oscillator
- SBCF 85.71
- NVAX 12.67
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.